Skip navigation
All CNBC  |  News  |  Video


Company: Alkermes Inc
Alkermes Inc : [ALKS  Loading...      ()   ]
Aug.31
8:55 AM ET
Monday, 31 Aug 2009
After a long delay, Eli Lilly finally launched its new bloodthinner Effient just this month. But analysts are already buzzing about what's next.    Read More
Jun.26
1:18 PM ET
Friday, 26 Jun 2009
Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon. Their research suggests the data is related to a suspected or "theoretical" higher cancer risk associated with SNY's Lantus.    Read More
Jun.04
2:34 PM ET
Thursday, 4 Jun 2009
In less than two weeks, there've been four pretty significant events in biopharma. And, hopefully, after ADA things will begin to settle down a bit for the summer.    Read More
May.26
1:10 PM ET
Tuesday, 26 May 2009
Much is understandably being made of the fact that Judge Sonia Sotomayor would be the first Hispanic to sit on the United States Supreme Court, assuming she's confirmed. But in my space, there could be a certain degree of buzz over something else in her background.    Read More
May.21
12:49 PM ET
Thursday, 21 May 2009
It's going to be a crazy busy, stressful couple of weeks. A shareholder meeting, a medical meeting, then another shareholder meeting and finally another medical meeting.    Read More
May.11
10:19 AM ET
Monday, 11 May 2009
Imagine my surprise when I got an email over the weekend from "Diabetic Investor" newsletter editor David Kliff informing me that Amylin Pharmaceuticals is quoting me in a letter to shareholders.    Read More
May.06
11:07 AM ET
Wednesday, 6 May 2009
You gotta love a good proxy fight, especially when you have one of the kings of shareholder activism, Carl Icahn, in the ring. And lately, I've been getting bombarded by emails from representatives of all corners.    Read More
May.05
12:22 PM ET
Tuesday, 5 May 2009
Fiesta time started a little earlier than expected for investors in Eli Lilly, Amylin Pharmaceuticals and Alkermes. The companies had said they would file for Food and Drug Administration approval of the once-a-week version of the diabetes drug Byetta in the second quarter, but most analysts thought that meant June.    Read More
VIDEO | COMPANIES : Alkermes Inc
Debating whether insider trading should be legalized, with Sam Antar, former Crazy Eddie Inc. CFO and Don Boudreaux, Geo...
Another take on the stock market and why it's sliding, with Peter Stock, Stock Investment Management Inc.
Small business owner Lani Hay, president and CEO of IT firm Lanmark Technology Inc., met with Vice President Biden and P...
Motorola reporting an unexpected third quarter profit, with Greg Brown, Motorola, Inc. Co-CEO.
How to trade Iraq, with Alli Ajha, Dinar Trade Inc. president.
News |  COMPANY : Alkermes Inc
Thursday, 5 Nov 2009
Source: The Associated Press
Tuesday, 7 Jul 2009
Source: The Associated Press
Tuesday, 5 May 2009
Source: CNBC staff and wire reports


Current DateTime: 01:00:15 10 Nov 2009
LinksList Documentid: 23188555



Current DateTime: 01:06:40 10 Nov 2009
LinksList Documentid: 23188557

Current DateTime: 02:47:39 10 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:04:27 10 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 04:56:52 10 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:06:24 10 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters